How have NXEN shares performed in 2024?

Nexien BioPharma's stock was trading at $0.0259 at the start of the year. Since then, NXEN shares have decreased by 21.8% and is now trading at $0.0203. View the best growth stocks for 2024 here .

Are investors shorting Nexien BioPharma?

Nexien BioPharma saw a increase in short interest in April. As of April 15th, there was short interest totaling 28,900 shares, an increase of 28,800.0% from the March 31st total of 100 shares. Based on an average trading volume of 22,100 shares, the short-interest ratio is currently 1.3 days. View Nexien BioPharma's Short Interest .

When is Nexien BioPharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 17th 2024. View our NXEN earnings forecast .

How do I buy shares of Nexien BioPharma?

Shares of NXEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:NXEN

Nexien BioPharma (NXEN) Stock Price, News & Analysis

→ Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad)

Free NXEN Stock Alerts

$0.02

0.00 (0.00%)

(As of 04/25/2024 ET)

Compare

Today's Range: $0.02
▼
$0.02
50-Day Range: $0.02
▼
$0.03
52-Week Range: $0.01
▼
$0.10

Volume: 1,221 shs
Average Volume: 13,565 shs
Market Capitalization: $1.37 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Financials SEC Filings Short Interest

Get Nexien BioPharma alerts:

Ad Stansberry Research

World’s biggest multibillionaire investor is buying THIS by the ton [picture]

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

Click here to find out what to do.

About Nexien BioPharma Stock (OTCMKTS:NXEN)

Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.

NXEN Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NXEN Stock News Headlines

April 26, 2024 | americanbankingnews.com

Nexien BioPharma, Inc. (OTCMKTS:NXEN) Short Interest Up 28,800.0% in April

October 31, 2023 | finance.yahoo.com

Nexien BioPharma, Inc. (NXEN)

See More Headlines

Receive NXEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nexien BioPharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/26/2024
Next Earnings (Estimated): 5/17/2024
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: OTCMKTS:NXEN
CUSIP: N/A
CIK: 1625288
Web: www.nexienbiopharma.com
Phone: (303) 495-7583
Fax: N/A
Employees: 4
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.01)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-360,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -869.86%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.01
Quick Ratio: 0.01

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 67,470,000
Free Float: 46,826,000
Market Cap: $1.37 million
Optionable: Not Optionable
Beta: 1.60

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Mr. Richard S. Greenberg (Age 75)
Founder, CEO, Executive VP & Chairman
Mr. Evan L. Wasoff CPA (Age 76)
Chief Financial Officer
Mr. Robert I. Goldfarb J.D. (Age 68)
Esq., Chief Operating Officer
Comp: $55k

Key Competitors

View All Competitors

NXEN Stock Analysis - Frequently Asked Questions

How have NXEN shares performed in 2024?: Nexien BioPharma's stock was trading at $0.0259 at the start of the year. Since then, NXEN shares have decreased by 21.8% and is now trading at $0.0203.
View the best growth stocks for 2024 here.
Are investors shorting Nexien BioPharma?: Nexien BioPharma saw a increase in short interest in April. As of April 15th, there was short interest totaling 28,900 shares, an increase of 28,800.0% from the March 31st total of 100 shares. Based on an average trading volume of 22,100 shares, the short-interest ratio is currently 1.3 days.
View Nexien BioPharma's Short Interest.
When is Nexien BioPharma's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, May 17th 2024.
View our NXEN earnings forecast.
How do I buy shares of Nexien BioPharma?: Shares of NXEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:NXEN) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial